Association between high risk papillomavirus DNA and nitric oxide release in the human uterine cervix

Gynecologic Oncology

Volumn 114, Issue 2, 2009, Pages 323-326

  Rahkola, Paivi ^a   Mikkola, Tomi S ^a   Ylikorkala, Olavi ^a   Vaisanen Tommiska, Mervi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cytology; Histology; Human papillomavirus; Nitric oxide

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ADULT; AGED; ARTICLE; CANDIDIASIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CYTOLOGY; DISEASE ASSOCIATION; DNA VIRUS; EPITHELIUM; FEMALE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PAPILLOMA VIRUS; PARITY; PRIORITY JOURNAL; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; VAGINITIS; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; NITRIC OXIDE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 67549100779     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.05.003     Document Type: Article

References (31)

1. Bosch F.X., and de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. J. Natl. Cancer Inst. Monogr. 31 (2003) 3-13
2. Giuliano A.R., Harris R., Sedjo R.L., Baldwin S., Roe D., Papenfuss M.R., et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the young women's health study. J. Infect. Dis. 186 (2002) 462-469
3. Stanley M. Immune responses to human papillomavirus. Vaccine 24 Suppl 1 (2006) S16-22
4. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 (2002) 244-265
5. Munoz N., Bosch F.X., de Sanjose S., Herrero L., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
6. Howard M., Sellors J., and Kaczorowski J. Optimizing the hybrid capture II human papillomavirus test to detect cervical intraepithelial neoplasia. Obstet. Gynecol. 100 (2002) 972-980
7. Sandri M.T., Lentati P., Benini E., DellÒrto P., Zorzino L., Carozzi F.M., et al. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J. Clin. Microbiol. 44 (2006) 2141-2146
8. Stevens M.P., Garland S.M., Rudland E., Tan J., Quinn M.A., and Tabrizi S.N. Comparison of the Digene hybrid capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal pap smear results. J. Clin. Microbiol. 45 (2007) 2130-2137
9. Peranzoni E., Marigo I., Dolcetti L., Ugel S., Sonda N., Taschin E., et al. Role of arginine metabolism in immunity and immunopathology. Immunobiology 212 (2007) 795-812
10. Tornblom S.A., Maul H., Klimaviciute A., Garfield R.E., Bystrom B., Malmstrom A., et al. mRNA expression and localization of bNOS, eNOS and iNOS in human cervix at preterm and term labour. Reprod. Biol. Endocrinol. 3 (2005) 33
11. De Andrea M., Mondini M., Azzimonti B., Dellòste V., Germano S., Gaudino G., et al. Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression. Virus Res. 124 (2007) 220-225
12. Hiraku Y., Tabata T., Ma N., Murata M., Ding X., and Kawanishi S. Nitrative and oxidative DNA damage in cervical intraepithelial neoplasia associated with human papilloma virus infection. Cancer Sci. 98 (2007) 964-972
13. Mazibrada J., Ritta M., Mondini M., De Andrea M., Azzimonti B., Borgogna C., et al. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol. Oncol. 108 (2008) 112-120
14. Bogdan C., Rollinghoff M., and Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12 (2000) 64-76
15. Fukumura D., Kashiwagi S., and Jain R.K. The role of nitric oxide in tumour progression. Nat. Rev. Cancer 6 (2006) 521-534
16. Ridnour L.A., Thomas D.D., Donzelli S., Espey M.G., Roberts D.D., Wink D.A., et al. The biphasic nature of nitric oxide responses in tumor biology. Antioxid. Redox Signal. 8 (2006) 1329-1337
17. Rahkola P., Mikkola T.S., Nieminen P., Ylikorkala O., and Vaisanen-Tommiska M. Abnormal cervical cytology is associated with increased cervical nitric oxide release in the uterine cervix. Acta Obstet. Gynecol. Scand. 88 (2009) 417-421
18. Vaisanen-Tommiska M., Nuutila M., Aittomaki K., Hiilesmaa V., and Ylikorkala O. Nitric oxide metabolites in cervical fluid during pregnancy: further evidence for the role of cervical nitric oxide in cervical ripening. Am. J. Obstet. Gynecol. 188 (2003) 779-785
19. Smith J.H. Bethesda 2001. Cytopathology 13 (2002) 4-10
20. Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P., et al. Carcinoma of the cervix uteri. Int. J. Gynaecol. Obstet. 83 Suppl 1 (2003) 41-78
21. Vaisanen-Tommiska M., Mikkola T.S., and Ylikorkala O. Increased release of cervical nitric oxide in spontaneous abortion before clinical symptoms: a possible mechanism for preabortal cervical ripening. J. Clin. Endocrinol. Metab. 89 (2004) 5622-5626
22. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004) 677-686
23. Woo Y.L., Sterling J., Damay I., Coleman N., Crawford R., van der Burg S.H., et al. Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysis. BJOG 115 (2008) 1616-1622
24. Hammes L.S., Tekmal R.R., Naud P., Edelweiss M.I., Kirma N., Valente P.T., et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression - clinicopathological correlation. Gynecol. Oncol. 105 (2007) 157-165
25. Tay S.K., Jenkins D., Maddox P., Hogg N., and Singer A. Tissue macrophage response in human papillomavirus infection and cervical intraepithelial neoplasia. BJOG 94 (1987) 1094-1097
26. Fernandes A.P., Goncalves M.A., Duarte G., Cunha F.Q., Simoes R.T., and Donadi E.A. HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels. Virology 334 (2005) 294-298
27. Scott M., Nakagawa M., and Moscicki A.B. Cell-mediated immune response to human papillomavirus infection. Clin. Diagn. Lab. Immunol. 8 (2001) 209-220
28. Karpuzoglu E., and Ahmed S.A. Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis. Nitric Oxide 15 (2006) 177-186
29. Akaike T., and Maeda H. Nitric oxide and virus infection. Immunology 101 (2000) 300-308
30. Zaki M.H., Akuta T., and Akaike T. Nitric oxide-induced nitrative stress involved in microbial pathogenesis. J. Pharmacol. Sci. 98 (2005) 117-129
31. Wright Jr. T.C., Cox J.T., Massad L.S., Carlson J., Twiggs L.B., Wilkinson E.J., et al. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. J. Low. Genit. Tract Dis. 7 (2003) 154-167